ENT department, Coimbra university hospitals, Praceta Mota Pinto, 3000 Coimbra, Portugal.
Pathology department, Oporto oncology institute, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Apr;131(2):83-6. doi: 10.1016/j.anorl.2012.11.007. Epub 2014 Mar 18.
The purpose of this study was to analyze the outcome of patients suffering from head and neck sarcomas and to identify indicators of outcome.
The medical records of 43 patients treated between 2000 and 2010 were analyzed. All patients were suffering from primary head and neck sarcoma. The final study sample included 29 patients.
Mean survival was 56 months. Overall 2- and 5-year survivorship was 69% and 31% respectively. Parameters positively influencing survival were: male gender; non-smoker; alcohol consumption; age <18 years; tumor size <5 cm; location (nasal pyramid, jaw and maxillary sinus). Rhabdomyosarcoma and synovial sarcoma were the histological forms positively influencing prognosis. Age was the only parameter significantly influencing survival (P<0.05).
The present overall 5-year survivorship was similar to the lower limit of the available literature data. Age was the only proven indicator of outcome. In order to have more reliable data it is essential to set up broader databases.
本研究旨在分析头颈部肉瘤患者的预后,并确定预后的指标。
分析了 2000 年至 2010 年间治疗的 43 名患者的病历。所有患者均患有原发性头颈部肉瘤。最终研究样本包括 29 名患者。
平均生存时间为 56 个月。总的 2 年和 5 年生存率分别为 69%和 31%。影响生存的参数有:男性;非吸烟者;饮酒;年龄<18 岁;肿瘤大小<5 cm;位置(鼻锥、颌骨和上颌窦)。横纹肌肉瘤和滑膜肉瘤是影响预后的组织学形式。年龄是唯一显著影响生存的参数(P<0.05)。
目前的 5 年总生存率与现有文献数据的下限相似。年龄是唯一被证实的预后指标。为了获得更可靠的数据,建立更广泛的数据库是必要的。